Pfizer and Moderna Vaccine Side Effects
The US drug regulator added a warning for the side effect of the Covid-19 vaccines made by Pfizer / BioNTech and Moderna, namely the rare risk of heart.
Read More...Get to Know Delta Plus Variant
The new variant of Covid-19 which is said to be highly contagious, namely Delta Plus, is increasingly spreading to a number of countries including the UK, the United States (US) and.
Read More...Panasonic Sells Tesla Shares
Panasonic Corp sold its stake in electric carmaker Tesla Inc for about 400 billion yen, or $3.61 billion, at the end of March. The sale comes as the conglomerate is trying to reduce its dependence on Tesla and raise money to invest in.
Read More...Windows 10 Free Upgrade
Windows 10 users can upgrade to Windows 11 for free. Microsoft states, users who have a Windows 10 license can upgrade for free to Windows.
Read More...Instagram can Upload Photos via Desktop
Instagram is testing the feature of posting or uploading photos via desktop. Through this feature, Instagram users will be able to upload photos or videos directly on a computer or laptop.
Read More...Windows 11 Can Run Android Apps
Windows 11 will be able to run Android applications directly on a laptop or PC. More practical, you don’t need to download and install an Android emulator on a laptop or.
Read More...WHO: Delta Variant Most Infectious
Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, said there was currently a lot of concern about the Delta variant. And, WHO is also worried about this new variant of the corona.
Read More...Bitcoin is Legal in El Salvador
El Salvador President Nayib Bukele said in a national address on Thursday that the law that was recently passed and made bitcoin legal would take effect on September 7, but that its use was.
Read More...Didi Chuxing’s Initial Public Offering
The ride-hailing giant from China, Didi Chuxing, is soon to be listed on the US stock exchange. The company has submitted an application to hold an initial public offering (IPO) at the relevant.
Read More...